2Cockerill FR 3rd,Smith TF. Response of the clinical microbiology laboratory to emerging (new) and reemerging infectious diseases. J Clin Microbiol, 2004, 42: 2359-2365.
3Infectious Diseases Society of America. Policy statement on consolidation of clinical microbiology laboratories. Clin Infect Dis, 2001, 32: 604.
4Boyce N. The health care systems′ changing climate. Clinical Laboratory News, 1996, 22:10.
5Peterson LR, Hamilton JD, Baron EJ, et al. Role of clinical microbiology laboratories in the management and control of infectious diseases and the delivery of health care. Clin Infect Dis, 2001, 32: 605-611.
6Hinman AR. Global progress in infectious disease control. Vaccine, 1998,16 :1116-1121.
7National Committee for Clinical Laboratory Standard. Performance standards for antimicrobial susceptibility testing; fourteenth informational supplement.NCCLS document M100-S14. Wayne.Pennsylvania:NCCLS, 2004.1-159.
8Pfaller MA, Herwaldt LA. The clinical microbiology laboratory and infection control: emerging pathogens, antimicrobial resistance, and new technology. Clin Infect Dis, 1997, 25: 858-870.
